The intersection of these three cancer-specific gene sets, comprising eleven genes (SLC4A10, KLRB1, ME1, TMIGD2, IL23R, NCR3, LST1, COLQ, RORC, ZBTB16, TLE1) that represent the most robust MAIT cell markers, was used for downstream analyses in bulk tumor transcriptomic datasets (Figure 5B). The gene discussed is TMIGD2; the disease is neoplasm.